NeuroImage · 2026
Potentially traumatic events and substance use do not predict changes in resting state functional connectivity in early adolescence.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Patel Herry, Aks Isabel R, Ralston Fiona A, Kemp Emily C, Pelham Iii William E, Tapert Susan F
Аннотация
Potentially traumatic events (PTEs) and substance use (SU) are commonly endorsed in early adolescence, a crucial period for neurodevelopment. PTEs and SU are precipitating events in the etiology of comorbid posttraumatic stress disorder (PTSD) and substance use disorder (SUD). Separately, they have been shown to alter within- and between-network connectivity in the three brain networks posited by Menon's Theory of Psychopathology: the default mode network (DMN), fronto-parietal network (FPN), and salience network (SN). While comorbid PTSD+SUD in adulthood shows shared neural underpinnings, this is less clear in adolescence. We analyzed the effects of PTEs and SU on resting state functional connectivity (rsFC) in 9-15 year olds from the Adolescent Brain Cognitive Development (ABCD) Study. Fixed effects panel models were fit to assess the effects of PTEs and SU on between-network (FPN-SN rsFC, DMN-SN rsFC, and FPN-DMN rsFC) and within-network (FPN rsFC, SN rsFC, and DMN rsFC) connectivity measured across three timepoints spanning two years. PTEs, SU, and their interaction were not significantly associated with between- and within-network rsFC two years later. No sex specific interactions were observed. Results suggest rsFC changes observed in older adolescents and adults with comorbid PTSD+SUD do not developmentally translate to early adolescents endorsing PTEs+SU. Lack of impact on rsFC may indicate a potential buffer period in which PTEs and SU do not affect rsFC until later in development or after symptom onset following PTEs+SU.